Actually, I ask so as to be corrected:
The world’s first personalised mRNA cancer vaccine for melanoma halves the risk of patients dying or the disease returning, according to trial results that doctors described as “extremely impressive”.
Melanoma affects more than 150,000 people a year globally, according to 2020 figures from World Cancer Research Fund International.
Patients who received the vaccine after having a stage 3 or 4 melanoma removed had a 49% lower risk of dying or the disease recurring after three years, data presented at the world’s largest cancer conference showed. The NHS in the UK is among the organisations testing the jab.
I’ve a very vague idea running around my head. Rough mind – a rough idea not a rough mind, we all already know that.
So, it’s long been an idea that it would be really great if we could “vaccinate” the immune system to go eat cancers. This would require a cheap – in fact by the standards of the industry, very, very, cheap – method of producing vaccines. There are so many cancers, the “vaccine” would need to be personalised for each patient. We’d like to get that “vaccine” production price – not per shot, but per personalisation – down into the $100s or perhaps $1,000s per treatment.
Hmm, OK. Now, I’ve got this vaguery that that’s what mRNA was all about. Covid was a sidestep, it just happened to arrive as the tech was maturing. But the aim was always cancers.
So, am I right on this? Or is this something I’ve made up after the fact?
BlokeinGermanywhoisnowinmycountry?